semaglutide and dialysis EASD 2025: Pooled analysis highlights CV benefits of in patients Long-Term Effect of Semaglutide on

UK GLP-1 users report increased confidence, deeper intimacy, and new romantic opportunities, highlighting the emotional effects of weight loss medications.

A simplified graphic demonstrating the differences between endogenous and exogenous GLP-1

Get 50% off your first month of GEM

There is growing evidence that GLP-1-receptor agonist (GLP-1-RA) use in patients who regained weight after bariatric surgery has resulted in significant weight loss

Two large phase 3 trials found that oral semaglutide 14 mg did not slow cognitive or functional decline over 104 weeks in people with early symptomatic, amyloid-positive Alzheimers disease